Page 36 Bain Capital Helthcare

36
Bain Capital
Healthcare
“Forward-Looking
Pharmacists”
At 122 years old, Germany-based STADA’s global business got
a big boost from a global platform
STADA’s Busy Private Years
• Delists
• Acquires EMEA rights to anti-dandruff
brand Nizoral
• Moves into biosimilars space with
investment in BIOCEUTICALS
Arzneimittel AG
• Goes large in skin-care with acquisition
of OTC portfolio from GSK
• Launches Biosimilar Movymia
targeting osteoporosis
• Launches Bortezomib injectable anti-
cancer drug
• Acquires Walmark, a consumer-facing
company in Central Europe
• Invests in Takeda
2018
2019
2020
Bio Products Laboratory: Quick Facts
OVERVIEW
European manufacturer of prescription
generics and over-the-counter medicine
across more than 120 markets
HQ
Frankfurt, Germany
INVESTMENT
2017
INVESTORS
Bain Capital Private Equity
WEBSITE
www.stada.com